With over 20 years' industry experience in the innovation, development and marketing of medical ultrasound, Glen will greatly reinforce Mindray’s strength in the ultrasound business.
Mountain View, Calif. (PRWEB) July 19, 2016
Shenzhen Mindray Bio-Medical Electronics Co.,Ltd (Mindray), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the recent appointment of Mr. Glen McLaughlin, PhD., as chief product officer (CPO), Ultrasound for the company’s worldwide operations. McLaughlin will retain his current titles of president, ZONARE and the executive vice president of Ultrasound, Mindray North America.
The CPO position was created as a result of a retrospective review of Mindray’s ultrasound business strategy and in line with the newly set strategy that pivots on Mindray’s core business - specifically penetration into the global premium and high-end medical ultrasound market. McLaughlin will lead his team to work in close collaboration with premium and high-end ultrasound customers to ensure that Mindray’s ultrasound product strategy and development are aligned with their imaging requirements.
“With over 20 years' industry experience in the innovation, development and marketing of medical ultrasound, Glen will greatly reinforce Mindray’s strength in the ultrasound business, including strategic direction, product innovation and roadmap, as well as marketing,” said Haitao Huang, vice president of Mindray. “In addition to leading the innovative research of ZONE Sonography® Technology (ZST), Glen also will facilitate and participate in the Medical Imaging Systems business unit’s efforts in technology, product, marketing strategy and marketing activities planning.”
McLaughlin is the pioneer behind the development of ZST, which is a next generation ultrasound technology based primarily on software. ZST enables imaging developments such as Advanced Acoustic Acquisition™, a software acquisition technique that breaks with traditional line-by-line imaging and instead uses large zones to acquire 90 percent more echo data at speeds of up to 10 times faster than conventional systems. The results are crystal clear images with exceptional temporal accuracy bringing diagnostic confidence to all imaging challenges.
ZST also drives Dynamic Pixel Focusing™ where, automatically, every pixel is optimally focused in every frame, at every depth and every time. No other technology eliminates manual focal zones and reveals structural clarity from the skin line to depths of up to 40 centimeters (cm), whether the smallest of neonates or the largest of bariatric patients.
“We believe we have a tremendous opportunity to leverage our core technologies in order to expand solutions to meet the imaging needs of high-end and premium ultrasound users,” said McLaughlin. “In doing so, we can provide state-of-the-art ultrasound systems while providing outstanding value with ongoing upgrades to support excellence in patient care.”
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com
ZONARE is a wholly owned subsidiary of Mindray. The company is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and ZONE Sonography ™ Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. For more information, please visit http://www.zonare.com